Zyversa Therapeutics Inc expected to post a loss of $3.70 a share - Earnings Preview

Zyversa Therapeutics

10/05/2024 17:24

* Zyversa Therapeutics Inc  ZVSA.OQ   ZVSA.O  is expected
to report resultson May 13 (estimated) for the period ending
March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Zyversa Therapeutics Inc
is
for a loss of $3.70 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Zyversa
Therapeutics Inc is $70.00​, above​ its last closing price
of $5.28. ​​​

This summary was machine generated May 10 at 16:24 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)